RevCycleAI Brief
Published researchAI-enabled patient access and revenue cycle management platform combining software automation with services across authorization, coding, billing and collections.
✦ Ask RevCycleAI about Infinx Healthcare
Pro AI analystGo deeper on competitors, positioning, buyers, funding and market signals.
Unlock Ask RevCycleAI →Key findings
Research highlightsThe acquisition cadence suggests Infinx is becoming an RCM consolidator rather than a single-product automation vendor; watch whether the acquired capabilities become a coherent platform and whether cross-sell into larger provider organizations accelerates.
Acquired i3 Verticals' Healthcare Revenue Cycle Management business, expanding into academic medical centers and large provider groups
Acquired Glidian to expand prior authorization automation and laboratory market reach
RevCycleAI Intelligence Scores
MethodologyMarket Matrix: Emerging · Impact 30 · Capability 45
Funding & transaction history
1 trackedInfinx acquired i3 Verticals' healthcare revenue cycle management business and associated proprietary technology for approximately $96 million.